C hlamydia pneumoniae was first described in 1986. 1 Serological studies indicate that it is one of the most prevalent infectious agents worldwide, [2] [3] [4] with a wide range of clinical manifestations, chiefly affecting the respiratory tract. 5 Serological associations have also been demonstrated with coronary artery disease [6] [7] [8] and asymptomatic carotid atherosclerosis. 9 Our study was designed to test the association of C pneumoniae with stroke syndromes in the multiracial inner-city population of west Birmingham, England, after adjustments for several potential confounding variables. We subjected a proportion of stroke patients to cerebral CT and carotid arterial ultrasound examinations and measured blood concentrations of cholesterol, triglyceride, fibrinogen, and von Willebrand factor to elucidate the mechanism of any association between C pneumoniae and cerebrovascular disease.
Subjects and Methods

Study Subjects and Investigations
Approval for this project was obtained from the hospital ethical committee at the City Hospital, Birmingham. Subjects were older than 16 years, all were admitted to this hospital through the emergency department, and all gave informed consent to participate. All adult patients were initially considered to be eligible; recruitment was prospective and continued at a steady rate, so that subjects were admitted consecutively throughout a 24-month period (March 1993 through March 1995). Exclusion criteria were known immunodeficiency, hypergammaglobulinemia, connective tissue disease, and other autoimmune disease.
The World Health Organization definition of stroke was applied in this study, ie, rapidly developing signs of focal or global disturbance of cerebral function, with no apparent cause other than cerebrovascular disease. In this setting, fully evolved strokes were diagnosed when clinical neurological deficiency persisted for more than 24 hours or led to death, and TIAs were diagnosed when it resolved within 24 hours. Cases in which the diagnosis was uncertain, including those in which neurological deficit had resolved by the time of admission, were excluded. We also excluded all cases that were complicated by clinical or electrocardiographic evidence of acute myocardial ischemia or by clinical or radiological evidence of active pulmonary disease. Because cardiac disease so commonly accompanies cerebrovascular ischemia, we did not attempt to exclude patients with chronic cardiac disease.
Control subjects were selected randomly from all admissions to the emergency department with acute nonpulmonary, noncardiovascular disorders, provided that there was no evidence of active cardiac, vascular, or pulmonary disease; thus, there is no reason to suspect that they were predisposed to acquire C pneumoniae infection.
Blood was taken on admission (or within 12 to 24 hours, when immediate venipuncture was impossible). All patients were asked to return 2 to 3 months after discharge for convalescent blood sampling. Fasting blood samples were taken within 24 hours for serum cholesterol and triglyceride measurements, and cerebral CT and Doppler ultrasound examinations of the carotid arteries were performed within 10 days of admission. These investigations, which were ordered by the admitting physician, were not confined to any part of the study period or to any discernible subgroup of patients. We also selected patients who presented within 12 hours of the onset of neurological symptoms (to avoid a significant acute-phase response) for measurement of plasma fibrinogen and von Willebrand factor.
Demographic characteristics, medical history, smoking habit, drug therapy, and physical signs were recorded by the admitting medical staff; ethnic origin, smoking habit, and use of steroid medication were later confirmed by postal questionnaires. Townsend scores of socioeconomic deprivation were assigned to those subjects who lived in the West Midlands conurbation by linking postal code sectors to census enumeration districts. These scores, which include items that reflect predominantly personal and family income, may be considered to reflect the socioeconomic status of people living within a particular locality. 10 The higher the score (ie, the more strongly positive), the greater was the degree of social deprivation.
Serological Testing
In every case, 2 to 5 mL of serum was obtained by centrifugation within 6 hours and stored at Ϫ20°C until analysis; testing of admission and convalescent sera was deferred until both specimens were available. Each blood sample was labeled only with a serial number; thus, the investigator was blind to all patient data at the time of testing and remained so until statistical analysis of the results.
Sera were tested by one investigator using Maxiscreen Chlamydia MIF slides (IO International Ltd) and fluorescein-conjugated antihuman immunoglobulins. Only an even pattern of elementary body fluorescence was regarded as positive. In every batch of slides tested, two control serum preparations known to be positive for this organism and two negative control subjects were each applied to two slides. All sera were screened at a dilution of 1:8; thereafter, positive sera were tested at dilutions of 1:8 to 1:1024.
Acute infection or reinfection just before entry into the study was presumed to be indicated by titers of IgGՆ512, IgMՆ8, or-in patients who provided convalescent samples-IgG rising fourfold between initial and convalescent sampling. Titers indicating previous infection without recrudescence were presumed to be IgG 64 to 256 or IgAՆ8, provided that IgM could not be detected and there was no significant rise in IgG.
Rheumatoid factor was assayed in patients in whom connective tissue diseases were suspected on clinical grounds, despite insufficient evidence to exclude them from the study. C pneumoniae IgM antibodies were discounted for serological classification when rheumatoid factor was present because of nonspecific IgM reactivity.
Analysis of Data
We compared raw frequencies of acute (re)infection and previous infection between the stroke/TIA and control groups by simple univariate analyses, using 2 tests. We used a logistic regression modeling method, as implemented in the EGRET statistical package, to explore possible influences of ethnic origin (Caucasian, Asian, or Afro-Caribbean), age, sex, smoking habit (current or previous versus never), diabetes mellitus, steroid use, and Townsend score on any association of antibody levels with stroke/TIA. Therefore, we derived ORs expressing the associations of stroke/TIA with acute C pneumoniae (re)infection and previous infection, adjusted for potential confounding factors.
Finally, in the stroke/TIA patients only, we performed general linear model analyses of variance on cholesterol, triglyceride, fibrinogen, and von Willebrand factor concentrations, stratifying data by all potentially associated factors. Because cholesterol, triglyceride, and von Willebrand factor levels had very skewed distributions, we used their logarithmic (log e ) transforms for these analyses to stabilize variance.
Results
Study Subjects and Investigations
Twenty-six stroke/TIA patients and 312 potential control subjects were excluded by the criteria stated above, and 53 control subjects refused to participate. We recruited 1694 patients. One hundred seventy-six (10.4%) had been admitted with acute neurological dysfunction; fully evolved stroke syndromes were eventually diagnosed in 164 patients and TIAs in 12.
The remaining 1518 patients (89.6%) were assigned to the control group. In these patients, the primary indications for hospital admission were abdominal pain in 460, for which causes were established in 403 cases; chest pain, not suggestive of myocardial ischemia and for which no cause was found, in 91; malignant disease in 85; fractures of various bones in 77; urinary obstruction in 64; complications of diabetes mellitus in 44; and other miscellaneous medical and surgical diagnoses in 697.
The demographic characteristics of both groups are shown in Table 1 . They were broadly similar with respect to ethnic origin and sex. The stroke/TIA group had a higher mean age, a higher proportion of diabetics, more current and previous smokers, and more steroid users (although data on smoking habit and steroid use were incomplete). These potential confounding variables were taken into account by the logistic regression analysis.
Thirty-one stroke/TIA and 282 control patients (17.6% and 18.6%, respectively) returned for convalescent blood sampling within 160 days, at a mean of 98.6 (SD 36.7) days after admission. After 160 days, we judged that sera could no longer be regarded as convalescent, and we discarded them. The demographic characteristics of these 313 patients were broadly similar to those of the study groups that they represented ( Table 2) .
After patients with known connective tissue or other autoimmune disease were excluded, there remained in the study 21 stroke/TIA patients and 133 control subjects in whom we suspected connective tissue diseases on clinical grounds and whom we therefore tested for the presence of rheumatoid factor. When this test was positive, in 4 stroke/TIA patients and 24 control subjects, the finding of IgM antibodies was discounted for the diagnosis of acute C pneumoniae infection.
Acute infection was diagnosed solely from IgM titers in 14 stroke/TIA patients and 30 control subjects, of whom 14 stroke/TIA patients and 22 control subjects would otherwise have been defined by their IgG titers as previously infected. Nine stroke/TIA patients and 11 control subjects were older than 60 years and therefore were within the age group that has been associated with unsuspected rheumatoid factor production.
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Selected Abbreviations and Acronyms
CI ϭ confidence interval MIF ϭ microimmunofluorescence OR ϭ odds ratio TIA ϭ transient ischemic attack
Fasting serum total cholesterol concentrations were measured in 30 stroke and 421 control patients and fasting serum triglyceride levels in 28 stroke and 419 control patients. Plasma fibrinogen was measured in 71 stroke patients, and plasma von Willebrand factor was measured in 69 stroke patients. Seventyfive stroke patients underwent CT brain scanning, and 47 underwent carotid artery ultrasound examination.
Among the stroke/TIA patients, cerebral CT scans showed major nonhemorrhagic infarcts in 26, small-vessel infarcts in 23, intracerebral hemorrhage in 13, and no abnormality in 13 (12 of whom had TIAs). Carotid artery ultrasound examination showed arterial plaques in 35 stroke/TIA patients (29 of whom had clinical evidence of cerebral infarction) and was normal in 12.
C pneumoniae and Cerebral Ischemia
Of the 176 patients in the stroke/TIA group, 24 (13.6%) had serological evidence of acute (re)infection, 57 (32.4%) previous infection, and 95 (54.0%) no infection. In the control group of 1518 subjects, 87 (5.7%) had evidence of acute (re)infection, 193 (12.7%) previous infection, and 1238 (81.6%) no infection. On 2 analysis, there was a statistically significant difference (PϽ.05) between the stroke/TIA and control groups in the distribution of the three possible serological classifications-acute (re)infection, previous infection, and no infection. The crude ORs for stroke/TIA were 3.6 (95% CI, 2.2 to 5.9) for acute (re)infection and 3.9 (95% CI, 2.7 to 5.5) for previous infection. These analyses would change very little if we ignored IgM antibody titers from the 9 stroke/TIA patients and 11 control subjects older than 60 years who were not tested for rheumatoid factor and in whom we detected acute C pneumoniae infection solely on the basis of IgM.
Logistic regression analysis suggested statistically significant associations of stroke/TIA with both acute and previous C pneumoniae infection. After adjustment for ethnic origin, age, sex, diabetes mellitus, and smoking habit, the ORs for stroke/ analysis) or in pairs, in their distributions of acute (re)infection, previous infection, and no infection. In this comparison, however, the small number of cases limits the power of such tests to detect variation.
With regard to carotid artery ultrasound examination (in 47 stroke/TIA patients), acute (re)infection, previous infection, and no infection were found in 17.1%, 34.3%, and 48.6% of patients with arterial plaques compared with 16.7%, 41.7%, and 41.7%, respectively, of those without plaques. Again, there was no significant difference between the two groups in this respect, but the small number of cases limits the power to detect such a difference.
In stroke/TIA patients with serological evidence of acute (re)infection, previous infection, and no infection, mean (95% CI) fasting serum concentrations of cholesterol were 5.8 (5.0 to 6.6), 5.8 (5.2 to 6.4), and 5.5 (5.2 to 6.0) mmol/L, and mean (95% CI) fasting serum concentrations of triglyceride were 2.2 (1.7 to 2.9), 1.9 (1.6 to 2.3), and 1.9 (1.7 to 2.2) mmol/L. Mean (95% CI) plasma concentrations of fibrinogen were 11.2 (9.7 to 12.3), 11.5 (10.3 to 12.6), and 12.1 (10.9 to 13.2) mol/L, and mean (95% CI) plasma concentrations of plasma von Willebrand factor were 147 (127 to 167), 156 (139 to 172), and 150 (136 to 164) IU/dL, respectively. After adjustment by regression analysis for variations in ethnic origin, age, sex, and smoking habit, there were no significant differences in serum lipids, plasma fibrinogen, or plasma von Willebrand factor between stroke/TIA patients with acute C pneumoniae (re)infection, previous infection, and no infection.
We found no noteworthy statistical interactions (ie, effect modification) by ethnic origin, age, sex, smoking habit, diabetes mellitus, or steroid use with the C pneumoniae-stroke/ TIA associations.
Discussion Case Definition
We decided to include both fully evolved stroke syndromes and TIAs in this study, recognizing the fact that their differentiation (depending on whether clinical neurological deficit persisted for Ͼ24 hours) is somewhat arbitrary and that there are no a priori reasons to assume that different pathological processes apply in the pathogenesis of these two conditions. The World Health Organization definitions, used in this study, are widely accepted.
C pneumoniae and Cerebral Ischemia
The notion that infections may be partly responsible for vascular occlusive disease is not new. 12 Many workers have proposed a role in atherosclerosis for Coxsackie viruses, 13, 14 and cytomegalovirus infection is strongly associated with rapidly progressive coronary atherosclerosis in cardiac transplant recipients. 15, 16 Other putative associations of coronary artery disease include Helicobacter pylori 17 and dental sepsis. 18 However, the strongest infectious contender for a role in the pathogenesis of atheroma is C pneumoniae. Both in chronic coronary artery disease and in acute myocardial infarction, several workers have demonstrated high levels of antibodies to C pneumoniae. 6, 19 Inclusions reacting with C pneumoniae-specific antibodies have been reported in coronary arterial fatty streaks and fibrolipid atheromatous plaques, 20, 21 and C pneumoniae DNA has been demonstrated in plaques by the polymerase chain reaction. 22, 23 It is noteworthy that we found substantial levels of acute and previous infection in control subjects as well as stroke/TIA patients, reflecting the high incidence of C pneumoniae infection in our community. Nevertheless, the results of our study support an association between cerebrovascular disease and C pneumoniae infection and between acute cerebral ischemia and acute recrudescence of infection. They therefore agree with the results of Melnick et al, 9 who reported a significant cross-sectional association between previous C pneumoniae infection and atherosclerosis in carotid arteries.
Since it is possible that any correlation between infection and strokes might result from a common link to atherosclerosis, our failure to distinguish ischemic from hemorrhagic strokes in some patients might weaken the apparent association with C pneumoniae. However, among those patients who underwent CT and carotid ultrasound examinations, we could demonstrate no significant differences in levels of C pneumoniae antibodies between patients with major nonhemorrhagic infarcts, small-vessel infarcts, intracerebral hemorrhage, and no abnormality; nor could we demonstrate any significant differences between patients with and without arterial plaques. There were too few patients to allow differentiation between TIAs and fully evolved stroke syndromes.
Strategies to take account of potential confounding variables are essential in studies of C pneumoniae antibodies, which have been associated with increasing age, 24 male sex, 24, 25 and smoking. 24, 26 In this study we found no noteworthy interactions of these factors-or of ethnic origin, use of steroid medication, diabetes mellitus, or Townsend score-with the association between C pneumoniae and cerebral ischemia.
Several possible mechanisms have been proposed for a role of infection in the pathogenesis of atheroma.
12 Lipid metabolism is clearly important 27 ; for example, animal models have shown that circulating monocytes adhere to and penetrate the endothelium at an early stage in atherogenesis 28 and become engorged with oxidized LDL, thereby producing the "foam cells" that are so characteristic of atheroma. 29 LDL, whose concentration is increased in sepsis, becomes oxidized when free superoxide radicals are released from endothelial cells or monocyte-macrophages. 30 Oxidized LDL is a strong chemoattractant for monocytes 31 and may form a number of cytotoxic molecules important in vascular damage and plaque evolu-tion. 32 In our study there was no significant association of cholesterol or triglyceride levels with C pneumoniae antibodies, implying that a global dysregulation of lipid metabolism plays no part in the association with cerebral ischemia.
Thrombogenesis is intimately related to atherogenesis, and it is widely believed that prothrombotic states predispose to atherosclerotic vascular disease. Many factors may influence the development of these conditions, among which fibrinogen is probably the most important. 33, 34 High levels of this protein are significantly associated with peripheral vascular disease, in which they confer an increased risk of cardiac events and mortality. 35 Infection is known to increase blood concentrations of plasma fibrinogen, and in a recent study an increased plasma fibrinogen level was independently associated with seropositivity for C pneumoniae. 36 Fibrinogen and von Willebrand factor may be regarded as possible markers for a prothrombotic state and for endothelial damage, respectively. Neither was significantly associated with C pneumoniae seropositivity in our study, but since they were not measured in all patients, this observation demands some caution.
As discussed above, other infectious agents have been also implicated in atherosclerosis. We believe that the rise in specific antibody levels that we have observed is disproportionate to the nonspecific immunoglobulin increase that is associated with "acute-phase reactions"; but even so, this rise does not prove a causal role for C pneumoniae. The possibility that some of our subjects had polymicrobial infections and that C pneumoniae antibodies merely confound a more important association has not been addressed. In this respect, the interactions of diverse organisms may prove to be crucial and deserve to be investigated in future research.
Serological Testing
Various techniques are available to detect C pneumoniae antibodies. 37 The best and most widely used is the MIF assay, 38 which is time-consuming and subject to some operator variation but is sensitive and species-specific and reliably detects IgG, IgM, and lgA. 39 The kit that we used has been employed in several studies 2, 40 and performs similarly to other MIF assays. The principle that a fourfold rise in specific IgG antibody titer should constitute evidence of acute primary C pneumoniae infection is generally accepted. 41 However, the rise may not be seen for 8 to 10 weeks 42 and may persist for several months 43 ; we therefore decided to set a time limit of 160 days on the interval between initial and convalescent sera. In a single serum specimen, an IgG titer Ն512 can be interpreted as evidence of acute primary infection 44 or-particularly in older peoplereinfection or recrudescence of chronic or latent infection. 45 IgG titers Յ256 may persist for many months 46 and have generally been accepted (in a single serum specimen) as evidence of previous infection, 47 provided that there is no rise in IgM antibodies. In our study patients who had IgG titers Ն512 in the first serum and who gave convalescent samples invariably showed a fall in titers between the two sera, but some who had initial titers of 64 to 256 maintained them.
Many authors have employed these serological criteria, 48 -52 and a large study combining serology with an examination of pharyngeal swabs by polymerase chain reaction has provided evidence in support of them. 53 We chose to reject IgG titers Ͻ64 to minimize the probability of false-positive results. 54 Our decision to include IgA is justified by experimental evidence that it persists for more than 3 weeks in chronic infection. 55, 56 IgM is generally considered to signify acute primary infection. 38 A threshold titer of Ն16 has been proposed, with titers of 8 indicating "probable acute infection," 57 but we found no difference in the proportions of patients with IgM antibodies at these two titers in a pilot study and therefore saw no merit in drawing a distinction between such low levels of antibody production. It has been suggested 58 that rheumatoid factor may make the measurement of IgM antibodies unreliable, particularly in elderly patients. 11 For this reason, we excluded from the study all patients with known connective tissue or other autoimmune disease and measured rheumatoid factor in other cases in which such diseases were considered possible, discounting IgM antibodies when it was present. (The presence of connective tissue disease per se was not considered to be an important confounding variable. We therefore did not measure other markers of such diseases, such as antinuclear antibodies, which are not reported to interfere significantly with IgM assays.) As demonstrated above, ignoring IgM titers from the remaining patients older than 60 years would not have significantly altered the relationships of stroke/TIA to acute and chronic C pneumoniae infections.
Limitations of This Study
Not all stroke patients underwent cerebral CT and carotid artery ultrasound examinations and estimations of plasma fibrinogen and plasma von Willebrand factor, and no control subjects did so. Only limited conclusions can be drawn from these measurements.
Fasting serum total cholesterol and triglyceride were measured in only a third of all patients. We did not attempt to differentiate between HDL and LDL cholesterol, but we suggest that such a differentiation might be informative. Furthermore, our approach does not address the possibility of altered lipid metabolism or accumulation of cholesteryl esters within cells.
We believe that our strategy for preventing interference by rheumatoid factor in IgM measurement has allowed us to make a valid interpretation of the results. However, in the future we would recommend the routine absorption of sera with antihuman IgG, as advocated by Verkooyen et al.
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Conclusions
These data support the association of cerebrovascular disease with previous C pneumoniae infection and the association of acute stroke and TIAs with acute recrudescence of infection. We believe that more research to elucidate the mechanism(s) of these associations is warranted and that particular attention should be paid to dysregulation of thrombogenesis and lipid metabolism.
